| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.097 | 0.001 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |